National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 1240 [2023-00143]
Download as PDF
<![CDATA[
1240
Federal Register / Vol. 88, No. 5 / Monday, January 9, 2023 / Notices
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Xavier Becerra,
Secretary of Health and Human Services.
Dated: January 3, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00143 Filed 1–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods Communities of Practice
Webinar on Emerging Approaches for
Anchoring Biological Relevance of
New Approach Methodologies; Notice
of Public Webinar; Registration
Information
[FR Doc. 2023–00151 Filed 1–6–23; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM)
announces a public webinar ‘‘Emerging
Approaches for Anchoring Biological
Relevance of New Approach
Methodologies.’’ The webinar is
organized on behalf of ICCVAM by the
National Toxicology Program
Interagency Center for the Evaluation of
Alternative Toxicological Methods
(NICEATM). Interested persons may
participate via the web meeting
platform. Time will be allotted for
questions from the audience.
Information about the webinar and
registration are available at https://
ntp.niehs.nih.gov/go/commprac-2023.
DATES:
Webinar: January 30, 2023, 10:00 a.m.
to approximately 12:00 noon EST.
Registration for Webinar: January 10,
2023, until 12:00 noon EST January 30,
2023. Registration to view the webinar
is required.
ADDRESSES: Webinar web page: https://
ntp.niehs.nih.gov/go/commprac-2023.
FOR FURTHER INFORMATION CONTACT: Dr.
Nicole Kleinstreuer, Director,
NICEATM, email: nicole.kleinstreuer@
nih.gov, telephone: (984) 287–3150.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the
development and validation of toxicity
testing methods that protect human
health and the environment while
replacing, reducing, or refining animal
use. ICCVAM also provides guidance to
test method developers and facilitates
collaborations that promote the
development of new test methods. To
address these goals, ICCVAM will hold
a Communities of Practice webinar on
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS–2023–1—NIH/NIAID
117 (Adjuvant Development for Vaccines for
Infectious and Immune-Mediated Diseases).
Date: January 25, 2023.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G43,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Sandip Bhattacharyya,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G42, Rockville, MD 20852, (240) 292–0189,
sandip.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:21 Jan 06, 2023
Jkt 259001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
‘‘Emerging Approaches for Anchoring
Biological Relevance of New Approach
Methodologies.’’
‘‘New approach methodologies’’
(NAMs) refers to approaches that can be
used alone or in combination to provide
information on chemical hazard and
risk assessment without traditional
animal tests. Traditional approaches to
evaluating NAMs consider how well the
results of chemical tests using NAMs
correspond with the results of animal
tests of the same chemicals. However,
the usefulness of this approach is
limited, especially when the animal
results are variable, or the animal model
does not adequately represent the
species or effect of regulatory interest.
This webinar will discuss approaches
to build confidence in NAMs that are
based on evaluating the biological
relevance of the NAM to the species of
regulatory interest. Ongoing activities
and key insights will be described in
three presentations by speakers from the
academic and private sector focusing on
applications of small model organisms,
organs-on-chips, and models of
absorption, distribution, metabolism,
and excretion. The preliminary agenda
and additional information about
presentations will be posted at https://
ntp.niehs.nih.gov/go/commprac-2023 as
available.
Webinar and Registration: This
webinar is open to the public with time
scheduled for questions by participants
following each presentation.
Registration for the webinar is required.
Registration will open on or before
January 10, 2023 and remain open
through 12:00 noon EST on January 30,
2023. Registration is available at https://
ntp.niehs.nih.gov/go/commprac-2023.
Interested individuals are encouraged to
visit this web page to stay abreast of the
most current webinar information.
Registrants will receive instructions on
how to access and participate in the
webinar in the email confirming their
registration.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 17 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability. ICCVAM also
promotes the scientific validation and
regulatory acceptance of testing
methods that more accurately assess the
safety and hazards of chemicals and
products and replace, reduce, or refine
animal use.
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 88, Number 5 (Monday, January 9, 2023)]
[Notices]
[Page 1240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00143]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; PHS-2023-1--NIH/NIAID 117 (Adjuvant
Development for Vaccines for Infectious and Immune-Mediated
Diseases).
Date: January 25, 2023.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G43,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G42, Rockville, MD 20852, (240) 292-0189,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 3, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-00143 Filed 1-6-23; 8:45 am]
BILLING CODE 4140-01-P
